Portfolio company
NADMED
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company produces blood analysis kits and services for measuring NAD metabolites and glutathione levels for clinical laboratories, pharmaceutical companies and research institutions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
biocrates
This company produces mass spectrometry kits and software for quantitative metabolomics analysis for pharmaceutical companies, research institutions, and clinical laboratories.
Metabolon
This company develops metabolomics profiling kits and analysis services for pharmaceutical, biotechnology, and academic researchers to identify biomarkers and understand biological pathways.
4BASES
This company develops diagnostic genetic testing kits and sequencing reagents for healthcare professionals and clinical laboratories to support precision medicine and disease prevention.
BioSpeedia
This company develops and produces rapid diagnostic kits for infectious diseases for health professionals and clinical diagnostic markets.
Reme-D
This company develops molecular diagnostic kits for human and animal diseases to support healthcare providers and researchers in underserved regions.
NANOLYZE
This company develops waveguide microscopy equipment for real-time analysis of nanoparticles to support researchers in drug development and nanomedicine.
PhenoTA
This company develops automated blood testing technology using Raman spectroscopy and artificial intelligence for next-generation hematology laboratories.
Noscendo
This company develops bioinformatic software and diagnostic platforms to identify pathogens in bloodstream infections for hospitals and clinical laboratories.
